FDA NDC Directory · JSON-LD · Markdown

lansoprazole

NDC 30142-192 · HUMAN OTC DRUG · TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE

Labeler / ManufacturerKroger Company
Marketing categoryNew Drug Application (innovator) · App NDA208025
Dosage form / routeTABLET, ORALLY DISINTEGRATING, DELAYED RELEASE · ORAL
Active ingredientsLANSOPRAZOLE (15 mg/1)
Marketing started20190405
Package count1

External sources

Source: openFDA. Public-domain (CC0).